PYGM_HUMAN - dbPTM
PYGM_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID PYGM_HUMAN
UniProt AC P11217
Protein Name Glycogen phosphorylase, muscle form
Gene Name PYGM
Organism Homo sapiens (Human).
Sequence Length 842
Subcellular Localization
Protein Description Phosphorylase is an important allosteric enzyme in carbohydrate metabolism. Enzymes from different sources differ in their regulatory mechanisms and in their natural substrates. However, all known phosphorylases share catalytic and structural properties..
Protein Sequence MSRPLSDQEKRKQISVRGLAGVENVTELKKNFNRHLHFTLVKDRNVATPRDYYFALAHTVRDHLVGRWIRTQQHYYEKDPKRIYYLSLEFYMGRTLQNTMVNLALENACDEATYQLGLDMEELEEIEEDAGLGNGGLGRLAACFLDSMATLGLAAYGYGIRYEFGIFNQKISGGWQMEEADDWLRYGNPWEKARPEFTLPVHFYGHVEHTSQGAKWVDTQVVLAMPYDTPVPGYRNNVVNTMRLWSAKAPNDFNLKDFNVGGYIQAVLDRNLAENISRVLYPNDNFFEGKELRLKQEYFVVAATLQDIIRRFKSSKFGCRDPVRTNFDAFPDKVAIQLNDTHPSLAIPELMRILVDLERMDWDKAWDVTVRTCAYTNHTVLPEALERWPVHLLETLLPRHLQIIYEINQRFLNRVAAAFPGDVDRLRRMSLVEEGAVKRINMAHLCIAGSHAVNGVARIHSEILKKTIFKDFYELEPHKFQNKTNGITPRRWLVLCNPGLAEVIAERIGEDFISDLDQLRKLLSFVDDEAFIRDVAKVKQENKLKFAAYLEREYKVHINPNSLFDIQVKRIHEYKRQLLNCLHVITLYNRIKREPNKFFVPRTVMIGGKAAPGYHMAKMIIRLVTAIGDVVNHDPAVGDRLRVIFLENYRVSLAEKVIPAADLSEQISTAGTEASGTGNMKFMLNGALTIGTMDGANVEMAEEAGEENFFIFGMRVEDVDKLDQRGYNAQEYYDRIPELRQVIEQLSSGFFSPKQPDLFKDIVNMLMHHDRFKVFADYEDYIKCQEKVSALYKNPREWTRMVIRNIATSGKFSSDRTIAQYAREIWGVEPSRQRLPAPDEAI
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Phosphorylation------MSRPLSDQE
------CCCCCCHHH
42.4822673903
2Acetylation------MSRPLSDQE
------CCCCCCHHH
42.48-
6Phosphorylation--MSRPLSDQEKRKQ
--CCCCCCHHHHHHH
39.6730001349
11DimethylationPLSDQEKRKQISVRG
CCCHHHHHHHCCHHH
35.05-
11MethylationPLSDQEKRKQISVRG
CCCHHHHHHHCCHHH
35.05115372769
15PhosphorylationQEKRKQISVRGLAGV
HHHHHHCCHHHHCCC
11.8530278072
26PhosphorylationLAGVENVTELKKNFN
HCCCCCHHHHHHHHC
47.3726437602
39PhosphorylationFNRHLHFTLVKDRNV
HCCCEEEEEECCCCC
21.64-
42UbiquitinationHLHFTLVKDRNVATP
CEEEEEECCCCCCCC
54.8321906983
48PhosphorylationVKDRNVATPRDYYFA
ECCCCCCCCHHHHHH
17.9926437602
52PhosphorylationNVATPRDYYFALAHT
CCCCCHHHHHHHHHH
11.1928152594
53PhosphorylationVATPRDYYFALAHTV
CCCCHHHHHHHHHHH
6.1528152594
71PhosphorylationLVGRWIRTQQHYYEK
HHHHHHHHCCHHHHC
24.3626437602
76PhosphorylationIRTQQHYYEKDPKRI
HHHCCHHHHCCCCCE
17.8726437602
84PhosphorylationEKDPKRIYYLSLEFY
HCCCCCEEEEEEEEH
11.4624043423
85PhosphorylationKDPKRIYYLSLEFYM
CCCCCEEEEEEEEHH
6.3524043423
87PhosphorylationPKRIYYLSLEFYMGR
CCCEEEEEEEEHHCC
15.1024043423
91PhosphorylationYYLSLEFYMGRTLQN
EEEEEEEHHCCHHHH
6.8424043423
95PhosphorylationLEFYMGRTLQNTMVN
EEEHHCCHHHHHHHH
27.2827542207
99PhosphorylationMGRTLQNTMVNLALE
HCCHHHHHHHHHHHH
14.9927542207
113PhosphorylationENACDEATYQLGLDM
HCCCCHHHHHCCCCH
15.1127542207
114PhosphorylationNACDEATYQLGLDME
CCCCHHHHHCCCCHH
14.5927542207
160UbiquitinationLAAYGYGIRYEFGIF
HHHHCCCEEEEEEEE
2.9722817900
162NitrationAYGYGIRYEFGIFNQ
HHCCCEEEEEEEECC
17.43-
162PhosphorylationAYGYGIRYEFGIFNQ
HHCCCEEEEEEEECC
17.4320068231
186PhosphorylationEADDWLRYGNPWEKA
CCCCHHHCCCHHHHC
21.0525690035
198PhosphorylationEKARPEFTLPVHFYG
HHCCCCCEECEEEEE
28.6126437602
202UbiquitinationPEFTLPVHFYGHVEH
CCCEECEEEEEECEE
14.3123000965
204PhosphorylationFTLPVHFYGHVEHTS
CEECEEEEEECEECC
7.4626437602
207UbiquitinationPVHFYGHVEHTSQGA
CEEEEEECEECCCCC
5.1123000965
210PhosphorylationFYGHVEHTSQGAKWV
EEEECEECCCCCEEE
14.8326437602
219PhosphorylationQGAKWVDTQVVLAMP
CCCEEEEEEEEEECC
17.4023607784
227PhosphorylationQVVLAMPYDTPVPGY
EEEEECCCCCCCCCC
21.2623607784
229PhosphorylationVLAMPYDTPVPGYRN
EEECCCCCCCCCCCC
21.9723607784
234PhosphorylationYDTPVPGYRNNVVNT
CCCCCCCCCCCCHHH
12.2323607784
241PhosphorylationYRNNVVNTMRLWSAK
CCCCCHHHHHHHCCC
7.6426437602
248UbiquitinationTMRLWSAKAPNDFNL
HHHHHCCCCCCCCCC
59.8822817900
277PhosphorylationRNLAENISRVLYPND
HHHHHHHHCCCCCCC
28.1126437602
281PhosphorylationENISRVLYPNDNFFE
HHHHCCCCCCCCCCC
9.3528152594
290UbiquitinationNDNFFEGKELRLKQE
CCCCCCCCCCCCCCE
46.5123000965
295UbiquitinationEGKELRLKQEYFVVA
CCCCCCCCCEEHHHE
34.3523000965
298PhosphorylationELRLKQEYFVVAATL
CCCCCCEEHHHEHHH
10.1221406692
304PhosphorylationEYFVVAATLQDIIRR
EEHHHEHHHHHHHHH
18.4021406692
316AcetylationIRRFKSSKFGCRDPV
HHHHHHCCCCCCCCC
53.5222636571
325PhosphorylationGCRDPVRTNFDAFPD
CCCCCCCCCCCCCCC
40.2326437602
364SuccinylationLERMDWDKAWDVTVR
HHHCCHHHHHCEEEE
47.31-
372PhosphorylationAWDVTVRTCAYTNHT
HHCEEEEECCCCCCC
9.35-
395UbiquitinationWPVHLLETLLPRHLQ
CCHHHHHHHCHHHHH
33.3021890473
395PhosphorylationWPVHLLETLLPRHLQ
CCHHHHHHHCHHHHH
33.3022673903
430PhosphorylationVDRLRRMSLVEEGAV
HHHHHHHHHHHHCCC
27.7022777824
450PhosphorylationAHLCIAGSHAVNGVA
HHHHHHCHHHHCCHH
10.15-
461PhosphorylationNGVARIHSEILKKTI
CCHHHHCHHHHHHHH
24.7826437602
467PhosphorylationHSEILKKTIFKDFYE
CHHHHHHHHCCCHHH
30.02-
473PhosphorylationKTIFKDFYELEPHKF
HHHCCCHHHCCCHHC
29.7319764811
483UbiquitinationEPHKFQNKTNGITPR
CCHHCCCCCCCCCCC
32.3621890473
484PhosphorylationPHKFQNKTNGITPRR
CHHCCCCCCCCCCCC
46.3426437602
514PhosphorylationRIGEDFISDLDQLRK
HHCCCHHCCHHHHHH
31.9219764811
524PhosphorylationDQLRKLLSFVDDEAF
HHHHHHHHHCCHHHH
33.3922673903
537AcetylationAFIRDVAKVKQENKL
HHHHHHHHHHHHCCH
50.2220167786
568UbiquitinationNSLFDIQVKRIHEYK
CCCHHEEHHHHHHHH
4.6122817900
574PhosphorylationQVKRIHEYKRQLLNC
EHHHHHHHHHHHHHH
9.4126437602
603PhosphorylationNKFFVPRTVMIGGKA
CCCCCCCEEEECCEE
14.35-
609AcetylationRTVMIGGKAAPGYHM
CEEEECCEECCCHHH
35.8430591717
614PhosphorylationGGKAAPGYHMAKMII
CCEECCCHHHHHHHH
6.3328348404
618AcetylationAPGYHMAKMIIRLVT
CCCHHHHHHHHHHHH
24.0530591723
625PhosphorylationKMIIRLVTAIGDVVN
HHHHHHHHHHHHHHC
19.70-
656UbiquitinationYRVSLAEKVIPAADL
CCHHHHHHHCCHHHH
39.6022817900
666UbiquitinationPAADLSEQISTAGTE
CHHHHHHHHHCCCCC
31.4022817900
681OtherASGTGNMKFMLNGAL
CCCCCCCEEEECCEE
31.46-
681N6-(pyridoxal phosphate)lysineASGTGNMKFMLNGAL
CCCCCCCEEEECCEE
31.46-
732PhosphorylationRGYNAQEYYDRIPEL
CCCCHHHHHHHHHHH
9.8919764811
733PhosphorylationGYNAQEYYDRIPELR
CCCHHHHHHHHHHHH
9.6719764811
747PhosphorylationRQVIEQLSSGFFSPK
HHHHHHHHCCCCCCC
28.2726437602
748PhosphorylationQVIEQLSSGFFSPKQ
HHHHHHHCCCCCCCC
48.4926437602
752PhosphorylationQLSSGFFSPKQPDLF
HHHCCCCCCCCCCHH
29.0024719451
754UbiquitinationSSGFFSPKQPDLFKD
HCCCCCCCCCCHHHH
73.5822817900
789PhosphorylationIKCQEKVSALYKNPR
HHHHHHHHHHHCCHH
24.5126437602
792PhosphorylationQEKVSALYKNPREWT
HHHHHHHHCCHHHHH
14.40-
809PhosphorylationVIRNIATSGKFSSDR
HHHHHHHCCCCCCCH
30.8526437602
831PhosphorylationEIWGVEPSRQRLPAP
HHHCCCCCCCCCCCC
27.7826437602

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
15SPhosphorylationKinasePHK-FAMILY-GPS
15SPhosphorylationKinasePHK-Uniprot
15SPhosphorylationKinasePHK_GROUP-PhosphoELM

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
15SPhosphorylation

1150650

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of PYGM_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
NTAQ1_HUMANWDYHV1physical
25416956
GLGB_HUMANGBE1physical
26344197

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
232600Glycogen storage disease 5 (GSD5)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of PYGM_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-316, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Global phosphoproteome of HT-29 human colon adenocarcinoma cells.";
Kim J.-E., Tannenbaum S.R., White F.M.;
J. Proteome Res. 4:1339-1346(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-15, AND MASSSPECTROMETRY.
"Regulation of glycogen phosphorylase. Role of the peptide regionsurrounding the phosphoserine residue in determining enzymeproperties.";
Carty T.J., Tu J., Graves D.J.;
J. Biol. Chem. 250:4980-4985(1975).
Cited for: PHOSPHORYLATION AT SER-15.

TOP